Login

ARATANA THERAPEUTICS, INC. 3 SEC Filings

Filed On Filing
05 Feb 2019 Form 3: Hellums Rhonda Lynette, CHIEF FINANCIAL OFFICER

Holds 26,501 shares of Common Stock

22 Jan 2019 Form 3: Broadfin Healthcare Master Fund Ltd, 10% owner and 2 others

Holds 7,258,135 shares of Common Stock

09 Jan 2019 Form 3: Ready Christopher T, VP of Sales and Marketing

Holds 30,928 shares of Common Stock

09 Jan 2019 Form 3: Ayres John C, SEE REMARKS

Holds 98,091 shares of Common Stock

22 May 2018 Form 3: Robinson Lowell W, Director

No securities owned

22 May 2018 Form 3: Barbarosh Craig A., Director

No securities owned

11 May 2017 Form 3: Broadfin Healthcare Master Fund Ltd, 10% owner and 2 others

Holds 4,455,442 shares of Common Stock

01 Jul 2016 Form 3: Standridge Brent, Chief Operating Officer

Holds 25,000 shares of Common Stock

08 Aug 2014 Form 3: Hockaday Irvine O Jr, Director

Holds 64,985 shares of COMMON STOCK

24 Jun 2014 Form 3: Roche Robert P Jr, Director

No securities owned

28 Mar 2014 Form 3: Brinkley David L, Director

No securities owned

05 Feb 2014 Form 3: Brege Laura, Director

No securities owned

05 Feb 2014 Form 3: Raines Merilee, Director

No securities owned

22 Oct 2013 Form 3: Yarno Wendy L, Director

No securities owned

26 Jun 2013 Form 3: Avalon Ventures IX, L.p., 10% owner and 1 other
26 Jun 2013 Form 3: Vander Vort John, Director

Holds 180,505 shares of Common Stock

26 Jun 2013 Form 3: Mpm Bioventures V, L.p., 10% owner and 8 others

Holds 180,505 shares of Common Stock

26 Jun 2013 Form 3: Tooman Craig A, Director
26 Jun 2013 Form 3: Stephanus Julia A, CHIEF COMMERCIAL OFFICER

Holds 130,214 shares of COMMON STOCK

26 Jun 2013 Form 3: St Peter Steven, Director

Holds 520,859 shares of COMMON STOCK

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support